Analyst firms · Barclays · ACHC
Barclays ACHC price target and rating history
Acadia Healthcare Company Inc. (ACHC) · Health Care
Barclays rates Acadia Healthcare Company Inc. (ACHC) Equal Weight with a $35 price target, as of its latest action on Feb 28, 2025. It has published 3 rating actions on ACHC since August 2021, including 0 upgrades and 1 downgrade. Across 4 firms with a ACHC price target in the last 12 months, the median target is $22.
- Current rating
- Equal Weight
- Price target
- $35
- Median target, all firms
- $22
- Actions on ACHC
- 3
Barclays price target on ACHC
Every Barclays rating on ACHC
- Feb 28, 2025
- Mar 6, 2024
- Aug 12, 2021
How other firms rate ACHC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Raymond James | Outperform | $39 | Sep 28, 2026 |
| Jefferies | Buy | $30 | Jun 3, 2026 |
| Leerink Partners | Market Perform | $14 | Dec 3, 2025 |
| BofA Securities | Underperform | $13 | Dec 3, 2025 |
Questions about Barclays and ACHC
- What is Barclays's price target for ACHC?
- Barclays's latest stated price target for Acadia Healthcare Company Inc. (ACHC) is $35, from its action on Feb 28, 2025.
- What is Barclays's rating on ACHC?
- Barclays rates ACHC Equal Weight, a neutral rating, as of Feb 28, 2025.
- When did Barclays last change its view on ACHC?
- On Feb 28, 2025, Barclays downgrades to Equal Weight from Overweight, price target $43 to $35.
- How does Barclays's ACHC target compare with other analysts?
- Across 4 firms with a ACHC price target in the last 12 months, the median target is $22.
More ACHC rating histories
All Barclays ratingsACHC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.